Condition: Acute Myeloid Leukemia · Sponsor: Guangdong Provincial People's Hospital
To compare the efficacy and safty of ABC-14 regimen with the traditional "3+7" regimen or AB-14 regimen in the treatment of newly diagnosed acute myeloid leukaemia
This description comes directly from the study's public registry record.
Jianyu Weng · 020-83827812 · wengjianyu@gdph.org.cn
Du Xin · 020-83827812 · xind@gdph.org.cn
Always discuss trial participation with your own doctor first.
| Dongguan General Hosptial | Dongguan, Guangdong, China | Recruiting |
| Foshan First People's Hospital | Foshan, Guangdong, China | Recruiting |
| Guangdong Provincial People's Hospital | Guangzhou, Guangdong, China | Recruiting |
| Sun Yat-sen University Cancer Center | Guangzhou, Guangdong, China | Recruiting |
| The Fifth Affiliated Hospital of Guangzhou Medical University | Guangzhou, Guangdong, China | Recruiting |
| The First Affiliated Hospital of Guangdong Pharmaceutical University | Guangzhou, Guangdong, China | Recruiting |
| The First Affiliated Hospital of Guangzhou Medical University | Guangzhou, Guangdong, China | Recruiting |
| The First Affiliated Hospital of Jinan University | Guangzhou, Guangdong, China | Recruiting |
| The Second Affiliated Hospital of Guangzhou Medical University | Guangzhou, Guangdong, China | Recruiting |
| Shenzhen second people's Hospital | Shenzhen, Guangdong, China | Recruiting |
| Affiliated Hospital of Guangdong Medical University | Zhanjiang, Guangdong, China | Recruiting |
| Zhuhai General Hosptial | Zhuhai, Guangdong, China | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06451861